References These statements have not been evaluated by the Food and Drug Administration (FDA)
Researchers should note that PT-141 produces a transient, dose-dependent increase in blood pressure it must not be used by individuals with cardiovascular disease, uncontrolled hypertension, or high cardiovascular risk, and must not be self-administered or used outside a controlled laboratory environment
This product has this caution for lactating women to consult a doctor before use, especially those who have medical conditions while breastfeeding
For optimal effects, maintain a balanced diet and healthy lifestyle
15+ Years of Hormone Optimization Experience Gary Rudashevsky, APRN (founder), Nicolie Vogt, FNP-C, and Angela Elliott, APRN have successfully treated thousands of patients with hormone-related concerns